SCO‑792 alleviates HFD‑aggravated chronic pancreatitis by modulating the gut–pancreas axis via the AMPK/ACC and TLR4/NF‑κB signaling pathways - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

SCO-792 Reduces High-Fat Diet-Induced Chronic Pancreatitis by Influencing the Gut-Pancreas Interaction Through AMPK/ACC and TLR4/NF-κB Pathways

  • By

  • Yanru Kang

  • Ningning Sun

  • Weijie Yao

  • Jinyu Li

  • Hua Yin

  • Jiyue Wang

  • Zuozheng Wang

  • Shaoqi Yang

  • Xiaoli Yang

  • September 3, 2026

Share

Original Source(s)

SCO‑792 alleviates HFD‑aggravated chronic pancreatitis by modulating the gut–pancreas axis via the AMPK/ACC and TLR4/NF‑κB signaling pathways

  • by Yanru Kang, Ningning Sun, Weijie Yao, Jinyu Li, Hua Yin, Jiyue Wang, Zuozheng Wang, Shaoqi Yang, Xiaoli Yang

  • September 3, 2026

Related Content

Commentary: Assessment of treatment effectiveness, follow-up results, and recurrence patterns in children with Helicobacter pylori infection

Correction: Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infection

Short-term postoperative neurocognitive safety and recovery profiles of remimazolam tosilate combined with flumazenil vs. propofol in cirrhotic patients undergoing endoscopic variceal treatment: a randomized controlled trial